Laboratorios Farmaceuticos Rovi Stock Current Valuation
| ROVI Stock | EUR 53.05 0.55 1.05% |
Valuation analysis of Laboratorios Farmaceuticos helps investors to measure Laboratorios Farmaceuticos' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Laboratorios Farmaceuticos' price fluctuation is very steady at this time. Calculation of the real value of Laboratorios Farmaceuticos is based on 3 months time horizon. Increasing Laboratorios Farmaceuticos' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Laboratorios Farmaceuticos is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Laboratorios Stock. However, Laboratorios Farmaceuticos' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 53.05 | Real 43.5 | Hype 53.05 | Naive 51.53 |
The real value of Laboratorios Stock, also known as its intrinsic value, is the underlying worth of Laboratorios Farmaceuticos Company, which is reflected in its stock price. It is based on Laboratorios Farmaceuticos' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Laboratorios Farmaceuticos' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Laboratorios Farmaceuticos ROVI helps investors to forecast how Laboratorios stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Laboratorios Farmaceuticos more accurately as focusing exclusively on Laboratorios Farmaceuticos' fundamentals will not take into account other important factors: Laboratorios Farmaceuticos ROVI Company Current Valuation Analysis
Laboratorios Farmaceuticos' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Laboratorios Farmaceuticos Current Valuation | 1.93 B |
Most of Laboratorios Farmaceuticos' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Laboratorios Farmaceuticos ROVI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Laboratorios Farmaceuticos ROVI has a Current Valuation of 1.93 B. This is 86.58% lower than that of the Pharmaceuticals sector and 58.51% lower than that of the Health Care industry. The current valuation for all Spain stocks is 88.41% higher than that of the company.
Laboratorios Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratorios Farmaceuticos' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratorios Farmaceuticos could also be used in its relative valuation, which is a method of valuing Laboratorios Farmaceuticos by comparing valuation metrics of similar companies.Laboratorios Farmaceuticos is currently under evaluation in current valuation category among its peers.
Laboratorios Fundamentals
| Return On Equity | 0.39 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 1.93 B | |||
| Shares Outstanding | 51.32 M | |||
| Shares Owned By Insiders | 60.25 % | |||
| Shares Owned By Institutions | 17.88 % | |||
| Price To Earning | 43.87 X | |||
| Price To Book | 4.42 X | |||
| Price To Sales | 2.54 X | |||
| Revenue | 648.68 M | |||
| Gross Profit | 379.83 M | |||
| EBITDA | 204.66 M | |||
| Net Income | 182.63 M | |||
| Cash And Equivalents | 126.82 M | |||
| Cash Per Share | 2.26 X | |||
| Total Debt | 52.52 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 2.62 X | |||
| Book Value Per Share | 8.28 X | |||
| Cash Flow From Operations | 149.44 M | |||
| Earnings Per Share | 3.33 X | |||
| Price To Earnings To Growth | 3.17 X | |||
| Target Price | 68.09 | |||
| Number Of Employees | 1.75 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 2.1 B | |||
| Total Asset | 732.68 M | |||
| Z Score | 23.4 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 0.87 % | |||
| Net Asset | 732.68 M |
About Laboratorios Farmaceuticos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratorios Farmaceuticos ROVI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratorios Farmaceuticos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratorios Farmaceuticos ROVI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Laboratorios Stock
Laboratorios Farmaceuticos financial ratios help investors to determine whether Laboratorios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorios with respect to the benefits of owning Laboratorios Farmaceuticos security.